Summary of OPEXA THERAPEUTICS, INC.

Item 5.07 Submission of Matters to a Vote of Security Holders

The Annual Meeting of Shareholders for Opexa Therapeutics, Inc. ("Opexa") was held on November 15, 2012 (the "Annual Meeting"). Three proposals were submitted to shareholders as described in the 2012 Proxy Statement and were approved by shareholders at the Annual Meeting. The proposals and the results of the shareholder votes are as follows.

                                                     Broker
1.                                  For    Withheld Non-Votes
Proposal to elect five directors
for one-year terms:

David E. Jorden                  8,038,220 444,434  8,685,717
Gail J. Maderis                  7,822,155 660,499  8,685,717
Michael S. Richman               8,085,123 397,531  8,685,717
Scott B. Seaman                  7,859,607 623,047  8,685,717
Neil K. Warma                    7,797,742 684,912  8,685,717


                                                                   Broker
2.                                      For      Against  Abstain Non-Votes
Proposal to approve an Amendment
to the Restated Certificate of
Formation to effect a reverse stock
split of Opexa's common
stock, as determined by the Board

of Directors in its discretion, at a ratio of not less than 1-for-2 and not more than 1-for-4 14,663,333 2,373,941 131,097 0

Broker
3. For Against Abstain Non-Votes Proposal to ratify the appointment of MaloneBailey, LLP as independent auditors for the fiscal year ending December 31, 2012 16,234,984 625,768 307,619 0